Pulse lineResearch With Heart Logo

Sequence Kernel Association Analysis of Rare Variant Set Based on the Marginal Regression Model for Binary Traits.

TitleSequence Kernel Association Analysis of Rare Variant Set Based on the Marginal Regression Model for Binary Traits.
Publication TypeJournal Article
Year of Publication2015
AuthorsWu B, Pankow JS
Secondary AuthorsGuan W
JournalGenet Epidemiol
Volume39
Issue6
Pagination399-405
Date Published2015 Sep
ISSN1098-2272
KeywordsComputer Simulation, Diabetes Mellitus, Type 2, Female, Genetic Association Studies, Genetic Testing, Humans, Male, Middle Aged, Models, Genetic, Risk Factors
Abstract

Recent sequencing efforts have focused on exploring the influence of rare variants on the complex diseases. Gene level based tests by aggregating information across rare variants within a gene have become attractive to enrich the rare variant association signal. Among them, the sequence kernel association test (SKAT) has proved to be a very powerful method for jointly testing multiple rare variants within a gene. In this article, we explore an alternative SKAT. We propose to use the univariate likelihood ratio statistics from the marginal model for individual variants as input into the kernel association test. We show how to compute its significance P-value efficiently based on the asymptotic chi-square mixture distribution. We demonstrate through extensive numerical studies that the proposed method has competitive performance. Its usefulness is further illustrated with application to associations between rare exonic variants and type 2 diabetes (T2D) in the Atherosclerosis Risk in Communities (ARIC) study. We identified an exome-wide significant rare variant set in the gene ZZZ3 worthy of further investigations.

DOI10.1002/gepi.21913
Alternate JournalGenet Epidemiol
PubMed ID26282996
PubMed Central IDPMC4544778
Grant ListHHSN268201100012C / HL / NHLBI NIH HHS / United States
HHSN268201000010C / HL / NHLBI NIH HHS / United States
RC2 HL102419 / HL / NHLBI NIH HHS / United States
HHSN268201100001I / HL / NHLBI NIH HHS / United States
HHSN268201100009I / HL / NHLBI NIH HHS / United States
5RC2HL102419 / HL / NHLBI NIH HHS / United States
HHSN268201100010C / HL / NHLBI NIH HHS / United States
HHSN268201100008C / HL / NHLBI NIH HHS / United States
R01 CA134848 / CA / NCI NIH HHS / United States
HHSN268201100005G / HL / NHLBI NIH HHS / United States
HHSN268201100008I / HL / NHLBI NIH HHS / United States
GM083345 / GM / NIGMS NIH HHS / United States
CA134848 / CA / NCI NIH HHS / United States
HHSN268201100006C / HL / NHLBI NIH HHS / United States
HHSN268201100005I / HL / NHLBI NIH HHS / United States
HHSN268201100002C / WH / WHI NIH HHS / United States
HHSN268201100009C / HL / NHLBI NIH HHS / United States
R01 GM083345 / GM / NIGMS NIH HHS / United States
HHSN268201100005C / HL / NHLBI NIH HHS / United States
HHSN268201100002I / HL / NHLBI NIH HHS / United States
HHSN268201000012C / HL / NHLBI NIH HHS / United States
HHSN268201100001C / WH / WHI NIH HHS / United States